Skip to main content

and
  1. No Access

    Article

    Differentiation syndrome in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene

    Differentiation Syndrome, also known as all-trans retinoic acid (ATRA) syndrome, is a well-described clinical phenomenon occurring in patients with the M3 subtype of acute myeloid leukemia receiving ATRA chemo...

    Courtney D. DiNardo, Bonnie Ky, Dan T. Vogl, Paul Forfia, Alison Loren in Medical Oncology (2008)